Data-Driven Decision-Making for Addiction
(D2A Oregon Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to enhance how Oregon decision makers use data to address the opioid and methamphetamine crises. It tests a new strategy for creating user-friendly data products that assist leaders in making informed decisions on substance use services. Participants include decision makers or advisors involved in substance use policy or service delivery, such as executive directors or case managers. The trial divides participants into two groups: one group helps design customized data tools, while the other receives standard data products. As an unphased trial, this study allows participants to directly influence the development of innovative tools that could significantly improve decision-making in substance use services.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this implementation strategy is safe for decision-making?
Research shows no specific safety data for the Data-Driven Decision-Making for Addiction treatment. This project uses data to enhance decision-making for substance use services in Oregon. Labeled as "Not Applicable" for phase, the trial does not test a new drug or medical procedure, indicating no direct health risks to participants.
The project aims to provide better data to help prevent overdoses and improve substance use treatment. Participants will work with data tools, so the usual safety concerns of drug trials do not apply. This suggests the treatment is well-tolerated, as it involves using data rather than physical interventions.12345Why are researchers excited about this trial?
Researchers are excited about the Data2Action Oregon Project because it uses cutting-edge data-driven decision-making to tackle addiction. Unlike traditional treatments that often involve medication or counseling, this project focuses on tailoring data products to help healthcare providers make more informed decisions. One unique feature is the collaborative design sessions (CDS) where providers co-design data products, ensuring they are customized to their specific needs. This personalized approach aims to improve treatment outcomes by offering insights that are directly relevant to the provider's context, potentially revolutionizing how addiction is managed.
What evidence suggests that this trial's methods could be effective for improving substance use services?
Research shows that Oregon has the worst access to substance use services in the U.S. and the highest rates of opioid and methamphetamine use. The Data2Action Oregon Project aims to address these problems by using data science, such as predictive modeling, to improve decision-making in substance use services. This trial includes two groups: one group will participate in co-design sessions (CDS) to tailor data products, while the other group will not participate in CDS and will receive standardized data products. Studies have shown that using data can enhance services, help prevent overdoses, and address gaps in substance use services. By providing important data to decision-makers, this project seeks to create more effective policies and increase access to necessary treatments. The goal is to make informed decisions that lead to better outcomes for people struggling with addiction.12346
Are You a Good Fit for This Trial?
This trial is for decision-makers in Oregon involved with community services, public health, justice, advocacy groups, and payers. They need comprehensive data to tackle substance use issues and the opioid/methamphetamine epidemics. Participants should be those seeking to improve resource allocation for substance use services and overdose prevention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Co-Design Sessions (CDS)
Counties participate in Co-Design Sessions to co-design and tailor data products with the study team.
Data Product Release
Counties receive tailored or standardized data products depending on their group assignment.
Follow-up
Participants are monitored for the impact of data products on substance use service gaps and service-recipient outcomes.
What Are the Treatments Tested in This Trial?
Interventions
- Data2Action Oregon Project
Find a Clinic Near You
Who Is Running the Clinical Trial?
Chestnut Health Systems
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
University of California, San Diego
Collaborator